Driving research of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS),
Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia and Long Covid

Announcing The Ronald G. Tompkins Harvard ME/CFS Collaboration at the Harvard Affiliated Hospitals

To honor the memory of Ronald G. Tompkins, MD, ScD, we have a special announcement to share with the community. We have renamed the OMF funded Harvard ME/CFS Collaboration to The Ronald G. Tompkins Harvard ME/CFS Collaboration at the Harvard Affiliated Hospitals.

Dr. Tompkins was a brilliant and compassionate thought leader who passionately used his vast knowledge base and expertise to advance OMF funded research since he joined the OMF Scientific Advisory Board in 2014. Not only was he a gifted scientist and doctor, but he was a dedicated advocate for the patient community, committed to improving healthcare for all those impacted by related multisystem chronic, complex diseases (msCCD).

In 2018, OMF launched the ME/CFS Harvard Research Collaborative with Dr. Tompkins and Wenzhong Xiao, PhD as Co-Directors. The ultimate goal of this research iniative is to understand the underlying mechanisms and discover new treatments for Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS), msCCD and now Long COVID.

At The Ronald G. Tompkins ME/CFS Collaboration, we remain committed to honoring Dr. Tompkins’s legacy by continuing his life’s work; to transform patient care, and ultimately, find a cure for all those living with chronic, complex diseases.  

Learn more about Dr. Tompkins’ life and legacy.

During this mourning period, we invite you to share your messages and memories of Dr. Tompkins on our KudoBoard. We hope this board will serve as a virtual memorial where we can come together as a community to reflect and honor Ron’s incredible legacy.

We will all miss him greatly but he will always be with us in our hearts.

With hope for all,
Linda Tannenbaum

Founder & CEO/President

Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS) Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia Leading Research. Delivering Hope.Open Medicine Foundation®

What are the advantages of giving from your Donor Advised Fund (DAF)?

  • Your gifts to your donor advised fund entitle you to an immediate income tax deduction at the time of contribution.
  • You avoid capital gains tax on appreciated assets you place in your donor advised fund.
  • Your fund’s investment gains accumulate tax free.
  • Funds are distributed to Open Medicine Foundation in your name and immediately put to use to support our worldwide research efforts.

How do I make a donation through my DAF?

Just click on the DAF widget below. It is simple and convenient to find your fund among the over 900 funds in our system.

Still can’t find your fund? 

  • Request a grant distribution through your Donor Advised Fund sponsor
  • Be sure to use OMF’s EIN #26-4712664
  • You can also designate OMF as a beneficiary for your Donor Advised Fund
  • Questions? Give us a call at 650-242-8669